The premature passing of rugby legend Rob Burrow as a consequence of motor neuron disease, one of far too many rare and not-so-rare incurable illnesses, is a reminder of how much remains to be done therapeutically to provide all people the chance at a reasonable quality and duration of life. Millions of people still suffer from […]
Tailored application of digital and technological advancements can generate novel solutions for gender-specific medical and health issues. The Tech4Eva event in Bern, Switzerland on the 13th of May, 2024, hosted by the EPFL Innovation Park and GroupeMutuel highlighted promising examples of how solutions to often-overlooked problems could have a transformative impact for individuals’ health and in […]
The pharmaceutical industry is enveloped in excitement around applying GenAI to accelerate drug discovery and introduction of new therapeutics to the market. As summarised by McKinsey & Co and others, AI implementation across life science domains from early research and discovery to clinical development and regulatory to operations, commercial, and medical affairs, to post-market surveillance […]
I attended the Avoiding Bias in AI Symposium hosted by the Center for AI in Medicine at the University of Bern on the 7th of March. In recognition of International Women’s Day, I am devoting this blog to highlighting the gender biases embedded in society and the vast quantities of data which are used to train advanced […]
By approving equal financing of medical treatments regardless of where the treatment takes place, the Swiss parliament has opened the door to considerable potential savings in health care provision while maintaining or improving quality, not by changing reimbursement amounts, but by aligning stakeholder interests conducive to efficiency and cost savings. SRF article: https://www.srf.ch/news/schweiz/einheitliche-finanzierung-das-parlament-wagt-die-grosse-gesundheitsreform By altering […]
McKinsey and Co’s Top 8 Priorities of CEOs in 2024 released in December 2023 names GenAI and outcompeting with technology as two of the priority areas. They identify the greatest added value for GenAI and technology for customer operations, marketing and sales, software engineering, and research and development, amounting to several $ trillion in value that […]
The Basel Chamber of Commerce Life Sciences Cluster organised a tremendous forum hosted by Novartis in Basel on November 13, 2023 to discuss progress on collaborative initiatives to promote the digitisation and standardisation of health and medical data across Switzerland. All parties are in agreement that a standardised framework of documenting medical information is an important […]
This week the CEO and CTO of QuadraticMed met with the new pharma head of Unit8. We are excited to be expanding our collaborative work to ensure our synergistic competencies deliver transformative services for the pharma, health, and life science sectors. […]
I was pleased to be invited to present QuadraticMed at the “Bern Takes Off!” startup event hosted by Helvetia. It was a pleasure to connect with a diverse range of companies operating in and around Bern. The event provided the opportunity to discuss with them how they process and handle information and derive decisions within […]
The second challenge in AI implementation, especially within the health sector, highlighted at the Intelligent Health AI conference revolves around the growing disparity between the rapid evolution of AI technologies and the readiness of users to effectively integrate them. In the corporate world, there is a swifter adoption of data-driven approaches, leading to enhanced productivity. […]